IP Library Granted Patent US 8,491,937
Granted Patent B2
US 8,491,937 · App. 11/706,923 · Granted Jul 23, 2013

Stability in vitamin and mineral supplements

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,491,937
App. No.
11/706,923
Granted
Jul 23, 2013
Kind
B2
Abstract

The invention provides a multivitamin and mineral nutritional supplement composition comprising at least one polyvalent metal and at least one oxidizable vitamin with substantially improved resistance to reactions that lead to darkening and/or spotting and reactions that may reduce the potency of oxidizable vitamins. The composition is a multivitamin and mineral composition comprising at least one polyvalent metal and at least one oxidizable vitamin wherein the composition is substantially free of mobile bound water. The invention also includes methods for making such a composition and methods of preventing or reducing oxidation, improving the stability of oxidizable vitamins, and stabilizing the disintegration time of a multi-vitamin and mineral nutritional supplement composition.

Claims (6)

1. A multivitamin and mineral composition comprising (a) at least one polyvalent metal selected from the group consisting of iron, magnesium, zinc, selenium, copper, cobalt, manganese, molybdenum, vanadium, nickel, tin, chromium and combinations thereof and (b) at least one oxidizable vitamin selected from the group consisting of Vitamin C, Vitamin E, Vitamin A, Vitamin A precursors, Vitamin B 6 , Vitamin D 3 , Vitamin K, folic acid and combinations thereof, and (c) anhydrous dicalcium phosphate, and (d) niacin and (e) pantothenic acid; wherein (i) the composition is substantially free of mobile bound water; (ii) the composition does not contain a hydrate form of any ingredient contained therein; (iii) the composition resists reactions that reduce the potency of oxidizable vitamins; (iv) the composition reduces oxidation induced spotting of the tablet; and (v) the composition stabilizes disintegration behavior of the tablet.

2. The multivitamin and mineral composition of claim 1 , further comprising a carotinoid.

3. A method for preparing a multivitamin and mineral composition comprising: providing (a) at least one oxidizable vitamin selected from the group consisting of Vitamin C, Vitamin E, Vitamin A, Vitamin A precursors, Vitamin B 6 , Vitamin D 3 , Vitamin K, folic acid and combinations thereof and (b) at least one polyvalent metal ion selected from the group consisting of iron, magnesium, zinc, selenium, copper, cobalt, manganese, molybdenum, vanadium, nickel, tin, chromium and combinations thereof and (c) anhydrous dicalcium phosphate; (d) niacin and (e) pantothenic acid; and combining the at least one polyvalent mineral ion, the at least one oxidizable vitamin and anhydrous dicalcium phosphate to form a composition wherein (i) the composition is substantially free of mobile bound water; (ii) the composition does not contain a hydrate form of any ingredient contained therein; (iii) the composition resists reactions that reduce the potency of oxidizable vitamins; (iv) the composition reduces oxidation induced spotting of the tablet; and (v) the composition stabilizes disintegration behavior of the tablet.

4. A method for preparing a multivitamin and mineral tablet comprising: combining (a) at least one polyvalent metal selected from the group consisting of iron, magnesium, zinc, selenium, copper, cobalt, manganese, molybdenum, vanadium, nickel, tin, chromium and combinations thereof, and (b) at least one oxidizable vitamin selected from the group consisting of Vitamin C, Vitamin E, Vitamin A, Vitamin A precursors, Vitamin B 6 , Vitamin D 3 , folic acid and combinations thereof and (c) anhydrous dicalcium phosphate (d) niacin and (e) pantothenic acid, to form a composition, wherein (i) the composition is substantially free of mobile bound water; (ii) the composition does not contain a hydrate form of any ingredient contained therein; (iii) the composition resists reactions that reduce potency of oxidizable vitamins; (iv) the composition reduces oxidation induced spotting of the tablet; and (v) the composition stabilizes disintegration behavior of the tablet.

5. A multivitamin and mineral supplement comprising about 15 to about 600 mg vitamin C; and about 20 IU to about 200 IU Vitamin E; about 0 to about 400 mg magnesium, about 0 to about 50 mg zinc, about 0 to about 12 mg manganese, about 0 to about 4 mg copper, about 0 to about 300 mcg chromium and about 0 to about 18 mg iron; and a therapeutically effective amount of niacin and pantothenic acid; and anhydrous dicalcium phosphate and further wherein (i) the supplement is substantially free of mobile bound water; (ii) the supplement does not contain a hydrate form of any ingredient contained therein; (iii) the supplement resists reactions that reduce the potency of oxidizable vitamins; (iv) the supplement reduces oxidation induced spotting of the tablet; and (v) the supplement stabilizes disintegration behavior of the tablet.

6. A method for preparing multivitamin and mineral tablets comprising: combining at least one polyvalent metal selected from the group consisting of iron, magnesium, zinc, selenium, copper, cobalt, manganese, molybdenum, vanadium, nickel, tin, chromium and combinations thereof, and at least one oxidizable vitamin selected from the group consisting of Vitamin C, Vitamin E, Vitamin A, Vitamin A precursors, Vitamin B 6 , Vitamin D 3 , folic acid and combinations thereof to form a composition, wherein (i) the composition is substantially free of mobile bound water; (ii) the composition does not contain a hydrate form of any ingredient contained therein; (iii) the composition resists reactions that reduce the potency of oxidizable vitamins; (iv) the composition reduces oxidation induced spotting of the tablet; and (v) the composition stabilizes disintegration behavior of the tablet.

Assignments (5)
CHANGE OF NAME Recorded May 16, 2024
From: GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
To: HALEON US HOLDINGS LLC
Reel/Frame 067455/0799 →
MERGER AND CHANGE OF NAME Recorded Apr 6, 2022
From: PF CONSUMER HEALTHCARE 1 LLC; GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
To: GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
Reel/Frame 059620/0041 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2019
From: WYETH LLC
To: PF CONSUMER HEALTHCARE 1 LLC
Reel/Frame 050727/0184 →
ARTICLES OF ORGANIZATION-CONVERSION Recorded Feb 23, 2018
From: WYETH
To: WYETH LLC
Reel/Frame 045425/0578 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2007
From: GOLDBERG, ALAN M.; DILLS, STEVEN; MARK, WILLIAM; SUTTON, BRUCE; BYERLEY, CHAD
To: WYETH
Reel/Frame 019121/0125 →